AKT1 and Miyoshi myopathy: Accordingly, TRPV1 inhibition blocked CXCR4-dependent signaling, suppressing the phosphorylation of Erk1/2 and AKT kinases in response to CXCL12 stimulation in MM cells (Fig. 3d).